Banque Transatlantique Sa Sarepta Therapeutics, Inc. Transaction History
Banque Transatlantique Sa
- $5.69 Billion
- Q1 2025
A detailed history of Banque Transatlantique Sa transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Banque Transatlantique Sa holds 750 shares of SRPT stock, worth $28,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
750Holding current value
$28,425% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SRPT
# of Institutions
506Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$391 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$343 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$342 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$154 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$128 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $3.32B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...